Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
8327733
Reference Type
Journal Article
Title
Pharmacology of adenosine A(2A) receptors
Author(s)
Ongini, E; Fredholm, BB
Year
1996
Is Peer Reviewed?
1
Journal
Trends in Pharmacological Sciences
ISSN:
0165-6147
Publisher
Elsevier Ltd
Volume
17
Issue
10
Page Numbers
364-372
Language
English
DOI
10.1016/S0165-6147(96)10045-6
Abstract
Adenosine A(2A) receptors, which have been cloned from several mammalian species, are activated by physiological concentrations of adenosine to stimulate the formation of cAMP and other mediators. The A(2A) receptors are found on neutrophil leukocytes, platelets, blood vessels and, very abundantly, on some cells in the CNS. In the caudate nucleus they coexist with dopamine D2 receptors, and stimulation of A(2A) receptors causes a decrease in D2 receptor-mediated neurotransmission. Thus, drugs that act on A(2A) receptors can be used to modify dopaminergic neurotransmission known to be important in neurological and psychiatric disorders. In this review, Ennio Ongini and Bertil Fredholm describe how recently developed potent and selective A(2A) receptor antagonists can be used to delineate the physiological and pathological processes regulated by A(2A) receptors. Results from in vitro and in vivo pharmacological studies strengthen the notion that A(2A) receptors are an interesting target for drug development.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity